钆对比剂全程化药学服务共识

Consensus on whole-process pharmaceutical care for gadolinium-based contrast agents

为促进钆对比剂的临床合理使用,并为医师处方该类对比剂及药师审核处方提供参考,本共识工作组根据国内外指南和共识,发起《钆对比剂全程化药学服务共识》编写项目。该项目由南方医科大学珠江医院牵头,联合国内多家医疗机构的临床专家和药学专家等,针对钆对比剂的基本药理作用、分类、药代动力学、药效动力学、适应证、禁忌证、注意事项、用法用量及不良反应等重点内容进行了研讨、总结,最终形成本共识。共识的主要内容包括各类钆对比剂的概述、临床合理使用、安全性管理及全程化药学服务流程等,供各级医疗机构医师、药师参考。

In order to promote the rational clinical use of gadolinium-based contrast agents(GBCA) and to provide a reference for physicians to prescribe such contrast agents and for pharmacists to review prescriptions,the consensus working group launched the preparation project of “Consensus on whole-process pharmaceutical care for GBCA” according to domestic and foreign guidelines and consensus.The Zhujiang Hospital of Southern Medical University took the lead and cooperated with clinical experts and pharmaceutical experts from several domestic medical institutions to discuss and summarize the basic pharmacological effect of GBCA,types,pharmacokinetics,pharmacodynamics,indications,contraindications,precautions,usage and dosage,adverse drug reactions,and finally forms the consensus.The main contents of this consensus include an overview of various types of GBCA,rational clinical use of drugs,security management and whole-process pharmaceutical care process,etc.,for reference by physicians and pharmacists in medical institutions at all levels.